Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000875320-10-000038
Filing Date
2010-07-13
Accepted
2010-07-13 16:41:04
Documents
2
Period of Report
2010-07-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2371
2 attach_1.htm EX-24 3604
  Complete submission text file 0000875320-10-000038.txt   7607
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1005 DR D.B. TODD BLVD NASHVILLE TN 37208
Business Address
Riley Wayne Joseph (Reporting) CIK: 0001432895 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 10950593